Involvement of Platelet Activation by P2Y12 Receptor in the Development of Transplant Arteriosclerosis in Mice

被引:17
|
作者
Yashiro, Kenichi
Matsumoto, Yuji
Ihara, Hayato [2 ]
Suzuki, Yasuhiro
Kondo, Kazunao
Urano, Tetsumei [2 ]
Umemura, Kazuo [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Pharmacol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan
关键词
Platelet; P2Y(12) receptor; Carotid transplantation; Vasculopathy; Inflammation; CARDIAC ALLOGRAFTS; CAROTID ALLOGRAFTS; CYCLOSPORINE-A; ADP RECEPTOR; MOUSE MODEL; P-SELECTIN; EXPRESSION; CELLS; INFLAMMATION; DYNAMICS;
D O I
10.1097/TP.0b013e318196305a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although activated platelets influence inflammation by intraplatelet mediators in transplantation, their mechanism of involvement in the progression of transplant arteriosclerosis has not yet been elucidated. We, therefore, investigated this question using P2Y(12) receptor knockout (KO) mice, in which platelets cannot be aggregated by adenosine diphosphate stimulation. Methods. Carotid arteries from 129XI mice were orthotopically transplanted into wild-type or KO mice in a minor antigen(s)-mismatched strain combination. No immunosuppression was used. Grafts were harvested at 7, 14, 28, and 56 days after transplantation for morphometry and immunohistology. Fluorescence-activated cell sorting and quantitative real-time reverse-transcriptase polymerase chain reaction were performed at 7 and 14 days after transplantation. Results. The intima/media ratio of grafts in KO mice was significantly reduced compared with wild-type mice at 14,28, and 56 days after transplantation. Fluorescence-activated cell sorting analysis showed a significant reduction of platelet CD 154 expression and platelet-leukocyte aggregates in KO mice at 14 days after transplantation. Additionally, levels of intercellular adhesion molecule-1 and CD40 mRNA, and numbers of intercellular adhesion molecule-1- or CD40-positive cells in the grafts were lower in KO mice at 7 and 14 days after transplantation. These reductions resulted in a significant attenuation of CD45-positive leukocytes adhering to the graft vessel wall in KO mice at 14 days after transplantation. Conclusion. Diminished platelet function by P2Y(12) receptor deficiency attenuates initiation and strongly inhibits progression of transplant arteriosclerosis in mice by diminishing adhesion molecule expression and leukocyte accumulation in the grafts during the early phase after transplantation.
引用
收藏
页码:660 / 667
页数:8
相关论文
共 50 条
  • [31] P2Y12 receptor: platelet thrombus formation and medical interventions
    Moheimani, Fatemeh
    Jackson, Denise E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 572 - 587
  • [32] Platelet P2Y12 receptor inhibition by thienopyridines: status and future
    Porto, Italo
    Giubilato, Simona
    De Maria, Giovanni Luigi
    Blasucci, Luigi Marzio
    Crea, Filippo
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (09) : 1317 - 1332
  • [33] P2Y12, a new platelet ADP receptor, target of clopidogrel
    Savi, P
    Labouret, C
    Delesque, N
    Guette, F
    Lupker, J
    Herbert, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 379 - 383
  • [34] P2Y12 receptor: platelet thrombus formation and medical interventions
    Fatemeh Moheimani
    Denise E. Jackson
    International Journal of Hematology, 2012, 96 : 572 - 587
  • [35] Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity
    Léon, C
    Ravanat, C
    Freund, M
    Cazenave, JP
    Gachet, C
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (10) : 1941 - 1947
  • [36] Effects of P2Y12 inhibition on platelet function in renal transplant patients
    Graff, J
    Klinkhardt, U
    Gossmann, J
    Wahl, O
    Harder, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R153 - R153
  • [37] Premature Platelet Activation and Resistance to P2Y12 Inhibitors in Rasa3 Mutant Mice
    Bergmeier, Wolfgang
    Paul, David S.
    Stefanini, Lucia
    Robledo, Raymond F.
    Chan, E. Ricky
    Getz, Todd M.
    Piatt, Raymond
    Boulaftali, Yacine
    Adams, Mark D.
    Peters, Luanne L.
    BLOOD, 2014, 124 (21)
  • [38] The influence of variation in the P2Y12 receptor gene on the magnitude of in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, H. J.
    van Werkum, J. W.
    Rudez, G.
    Leebeek, F. W. G.
    Kruit, A.
    Hackeng, C. M.
    ten Berg, J. M.
    de Maat, M. P. M.
    Ruven, H. J. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 587 - 588
  • [39] P2Y12 receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation
    Chan, Melissa V.
    Knowles, Rebecca B. M.
    Lundberg, Martina H.
    Tucker, Arthur T.
    Mohamed, Nura A.
    Kirkby, Nicholas S.
    Armstrong, Paul C. J.
    Mitchell, Jane A.
    Warner, Timothy D.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (04) : 621 - 633
  • [40] P2Y12 receptor of platelets contributes to the development of allo-transplant arteriosclerosis in the carotid-artery and to the prolongation of heart allo-graft survival in mice.
    Yashiro, Kenichi
    Matsumoto, Yuji
    Suzuki, Yasuhiro
    Kondo, Kazunao
    Umemura, Kazuo
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 156 - 156